News
The sale comes after a wave of customers and government officials demanded that 23andMe protect the genetic data it had built ...
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback